FAST NEWS: 111 Inc. enters strategic supply agreement with Scrianen Pharma
The Latest: Pharmaceutical distributor 111 Inc. (YI.US) announced Tuesday that it has entered into a strategic direct supply partnership with drug developer and maker Beijing Scrianen Pharmaceutical. Looking Up: This…
YI.US
Recent Articles
RELATED ARTICLES
-
Inaugural operating profit fails to lift 111 Inc.
YI.US
- Margins ring alarm bells as 160 Health readies IPO
-
IFlytek hives off health unit to fund AI medical drive
002230.SHE
-
Ping An Health pins recovery hopes on new leadership
1833.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Slowing revenue growth hurts online drug platform YSB
9885.HK
-
Test results for new cancer drug take Akeso investors on wild ride
9926.HK
Discover hidden China stock gems in our weekly newsletter